Screener
Taysha Gene Therapies, Inc. TSHA Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-207666
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property, plant and equipment, net | 6,450 | 6,736 |
| Operating lease right-of-use assets | 9,155 | 9,439 |
| Other non-current assets | 181 | 183 |
| Total assets | $300,351 | $343,320 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $4,564 | $6,275 |
| Accrued expenses and other current liabilities | 15,534 | 20,277 |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s total assets?
- Taysha Gene Therapies, Inc. (TSHA) reported total assets of $300.35M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s total assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s total assets increased by 117.1% year-over-year, from $138.36M to $300.35M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total assets?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s total assets has grown at a 5.8% compound annual growth rate (CAGR), from $258.88M to $343.32M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Taysha Gene Therapies, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude